David Rendle Webinars

David Rendle BVSc MVM CertEM(IntMed) DipECEIM FRCVS

RCVS and European Specialist in Equine Internal Medicine

Independent Consultant
EMT Consulting

Prevention & Management of Laminitis (2021)

Presented by Dr. David Rendle. 
This webinar discusses the value of measuring insulin concentration in assessing the risk and prognosis for laminitis and goes on to highlight recent updates in the management of endocrinopathic laminitis and obesity. The pros and cons of different treatments are reviewed with reference to the published literature and also recent work that is yet to be published.

Managing Equine Gastric Disease – Part 1 (2021)

Presented by Dr. David Rendle. 
Join Dave to understand the differences in approach to Gastric disease – not as simple as we once thought! Squamous versus glandular gastric disease. Different options for treating squamous disease in Australia will be covered. Learn how to develop a logical approach to the management of challenging glandular disease cases. 

Managing Equine Gastric Disease – Part 2 (2021)

Presented by Dr. David Rendle. 
Join Dave to understand the differences in approach to Gastric disease – not as simple as we once thought! Squamous versus glandular gastric disease. Different options for treating squamous disease in Australia will be covered. Learn how to develop a logical approach to the management of challenging glandular disease cases. 

Compounding in the Veterinary Industry, an IVA Panel Discussion (2021)

Presented by Dr. Sue Foster, Nick Bova, Dr David Fowler, Dr Hubert Hiemstra, Dr Gerardo Poli

The use of compounded pharmaceuticals in veterinary practice has long been a topic of debate and conjecture. With patient outcomes being top of mind for practicing veterinarians, Independent Vets of Australia (IVA) has engaged a panel of experts in different sectors of the veterinary industry to shed light on and debunk some of the myths surrounding compounding in the veterinary industry.

Many veterinarians have experienced variances in patient response to compounded medication and Veterinarians have often asked, what guidelines or regulations do compounders have to adhere to? Is there a certain level of quality that has to be produced by a compounding pharmacy? Why do prices vary from compounder to compounder?

 

Managing endocrine cases through the Autumn and Winter (October 2021)

Presented by Dr. David Rendle. 

During this webinar you will get an update on the latest thinking in the diagnosis and treatment of EMS and PPID with a focus on care through the winter. Dave will guide you through the importance of weight loss through the winter months to prevent laminitis in the Spring, and will introduce novel therapeutics that are now being used for the management of EMS and laminitis risk. Diet and management strategies for obesity will be discussed. Recent studies on how the management of PPID can be optimised with pergolide and other treatments will be reviewed.

A heavyweight discussion: how do we tackle equine obesity? (May 2021)

With Tamzin Furtado, David Rendle, Nicola Menzies-Gow and Laura Sharpe.

During this live webinar David Rendle, Tamzin Furtado, and Nicola Menzies-Gow will chew the fat on obesity.
Tamzin Furtado will discuss how to raise the issue of obesity in a consult, and how to work with owners to create tailored weight plans.
David Rendle will present an argument for using pharmaceuticals to tackle obesity.
Nicola Menzies-Gow will present an argument for diet and exercise and not to use pharmaceuticals as a substitute.
Laura Sharpe from the George Veterinary Group will be our guest chairperson for the evening.

Treatment of Equine Gastric Disease (2020)

Presented by Dr. David Rendle. 
An international perspective and update on the treatment of gastric disease with presentation of recent and unpublished clinical research.  This webinar is certain to make you think about how you utilise different options in the management of squamous ulcers and glandular gastritis.


Updates on the treatment of equine gastric disease
(2019)

Presented by Dr. David Rendle. 
David will discuss options for the treatment of EGGD and ESGD and review recent published and as yet unpublished clinical research relating to the treatment of both conditions.